Superior HealthPlan Encourages Effort to Stop Prescription Drug Misuse

Go back to Superior HealthPlan Encourages Effort to Stop Prescription Drug Misuse

Centene (CNC) PT Raised to $85 at Jefferies; Reiterates Buy

April 26, 2017 9:21 AM EDT

Jefferies raised its price target on Centene (NYSE: CNC) to $85.00 (from $83.00) while maintaining a Buy rating. CNC reported 1Q EPS of $1.12, 8% ahead of consensus estimates. Higher revenue and lower MLR more than offset higher SG&A.

Analyst David Windley remains... More